Evidence map›Paper›PMID 41020001›Full record

ArticleFrontiers in pharmacology2025

Antibacterial and wound healing effects of PEG-coated ciprofloxacin-loaded ZIF-8 nanozymes against ciprofloxacin-resistant

Mohadeseh Pahlevani, Masoumeh Beig, Seyed Mahmoud Barzi, Milad Sadeghzadeh, Morvarid Shafiei, Mohsen Chiani, Aria Sohrabi, Mohammad Sholeh, Shaghayegh Nasr

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohadeseh Pahlevani *Department of Microbial Biotechnology, University of Science and Culture, Faculty of Modern Biological Sciences and Technologies, Tehran, Iran.
Masoumeh Beig *Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Seyed Mahmoud BarziDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Milad SadeghzadehDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Morvarid ShafieiDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Mohsen ChianiDepartment of Nanobiotechnology, New Technology Research Group, Pasteur Institute of Iran, Tehran, Iran.
Aria SohrabiDepartment of Epidemiology and Biostatics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Mohammad SholehDepartment of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Shaghayegh NasrDepartment of Microbial Biotechnology, University of Science and Culture, Faculty of Modern Biological Sciences and Technologies, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Antimicrobial-resistant (AMR) Methods: Clinical isolates of CRP were collected from burn patients and confirmed via polymerase chain reaction for the Results: Among 60 Conclusion: PEG-ZIF-8-CIP nanozymes effectively treated ciprofloxacin-resistant

Indexed as

burn woundsCIP-loaded nanozymesPEG-coated nanozymesPseudomonas aeruginosazeolitic imidazolate framework-8 (ZIF-8)

Identifiers

PMID41020001
PMCPMC12461262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.